ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 166 filers reported holding ALLAKOS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $344,000 | -90.5% | 35,152 | +2.7% | 0.00% | -90.9% |
| Q3 2021 | $3,623,000 | +72.4% | 34,219 | +39.1% | 0.01% | +57.1% |
| Q2 2021 | $2,101,000 | +5.3% | 24,605 | +41.5% | 0.01% | 0.0% |
| Q1 2021 | $1,995,000 | -46.1% | 17,384 | -34.3% | 0.01% | -46.2% |
| Q4 2020 | $3,702,000 | +78.0% | 26,440 | +3.5% | 0.01% | +62.5% |
| Q3 2020 | $2,080,000 | +4.7% | 25,543 | -7.6% | 0.01% | 0.0% |
| Q2 2020 | $1,986,000 | – | 27,639 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |